These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6826641)

  • 21. [Silver staining of reticular fibers in hematological preparations. I. Findings in plasmocytoma, macroglobulinemia & hyperglobulinemic purpura].
    VON BOROVICZENY KG
    Acta Haematol; 1959 Feb; 21(2):65-77. PubMed ID: 13626508
    [No Abstract]   [Full Text] [Related]  

  • 22. Prognostic impact of circulating plasma cells in patients with multiple myeloma: implications for plasma cell leukemia definition.
    Granell M; Calvo X; Garcia-Guiñón A; Escoda L; Abella E; Martínez CM; Teixidó M; Gimenez MT; Senín A; Sanz P; Campoy D; Vicent A; Arenillas L; Rosiñol L; Sierra J; Bladé J; de Larrea CF;
    Haematologica; 2017 Jun; 102(6):1099-1104. PubMed ID: 28255016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone-marrow plasmocytosis--an immunohistological study.
    Eckert F; Schmid L; Kradolfer D; Schmid U
    Blut; 1986 Jul; 53(1):11-9. PubMed ID: 3719110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Myeloma precursor cells and their differentiation].
    Kawano MM
    Nihon Rinsho; 1995 Mar; 53(3):552-6. PubMed ID: 7699884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of bone marrow plasma cell infiltration in stage I multiple myeloma.
    Cavo M; Baccarani M; Gobbi M; Lipizer A; Tura S
    Br J Haematol; 1983 Dec; 55(4):683-90. PubMed ID: 6671088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytodiagnosis of extramedullary plasmacytomas.
    Goel G; Rai S; Naik R; Gupta A; Baliga P; Sinha R
    Acta Cytol; 2010; 54(3):255-8. PubMed ID: 20518407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnetic resonance imaging as a supplement for the clinical staging system of Durie and Salmon?
    Baur A; Stäbler A; Nagel D; Lamerz R; Bartl R; Hiller E; Wendtner C; Bachner F; Reiser M
    Cancer; 2002 Sep; 95(6):1334-45. PubMed ID: 12216103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultrastructural studies on human myeloma plasmacytes.
    Smetana K; Gyorkey F; Gyorkey P; Busch H
    Cancer Res; 1973 Oct; 33(10):2300-9. PubMed ID: 4741931
    [No Abstract]   [Full Text] [Related]  

  • 29. [Multiple myeloma].
    Krome S
    Dtsch Med Wochenschr; 2012 Mar; 137 Suppl 1():S14-7. PubMed ID: 22438117
    [No Abstract]   [Full Text] [Related]  

  • 30. A further note on the ultrastructure of myeloma plasmacytes.
    Smetana K; Hermanský F; Koblízková H; Pospísil V
    Neoplasma; 1971; 18(1):3-13. PubMed ID: 4324994
    [No Abstract]   [Full Text] [Related]  

  • 31. [Research Progress on Multiple Myeloma with Extramedullary Disease].
    Wang L; Zhang YZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):945-8. PubMed ID: 27342539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prognostic value of the ratio of bone marrow plasma cells in multiple myeloma].
    Pasqualetti P; Colantonio D; Casale R
    Minerva Med; 1990 Mar; 81(3):129-33. PubMed ID: 2320280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Staging monoclonal plasma cell disease: comparison of the Durie-Salmon and the Durie-Salmon PLUS staging systems.
    Fechtner K; Hillengass J; Delorme S; Heiss C; Neben K; Goldschmidt H; Kauczor HU; Weber MA
    Radiology; 2010 Oct; 257(1):195-204. PubMed ID: 20851941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic criteria and histologic grading in multiple myeloma: histologic and immunohistologic analysis of 176 cases with clinical correlation.
    Sukpanichnant S; Cousar JB; Leelasiri A; Graber SE; Greer JP; Collins RD
    Hum Pathol; 1994 Mar; 25(3):308-18. PubMed ID: 8150462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of malignant plasma cell precursors in the bone marrow of multiple myeloma.
    Caligaris-Cappio F; Bergui L; Tesio L; Pizzolo G; Malavasi F; Chilosi M; Campana D; van Camp B; Janossy G
    J Clin Invest; 1985 Sep; 76(3):1243-51. PubMed ID: 2931452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. (18)F-FDG dynamic PET/CT in patients with multiple myeloma: patterns of tracer uptake and correlation with bone marrow plasma cell infiltration rate.
    Sachpekidis C; Mai EK; Goldschmidt H; Hillengass J; Hose D; Pan L; Haberkorn U; Dimitrakopoulou-Strauss A
    Clin Nucl Med; 2015 Jun; 40(6):e300-7. PubMed ID: 25783508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheral blood.
    Di Raimondo F; Azzaro MP; Palumbo G; Bagnato S; Giustolisi G; Floridia P; Sortino G; Giustolisi R
    Haematologica; 2000 Aug; 85(8):800-5. PubMed ID: 10942925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Plasma cell separation algorithm from bone marrow samples].
    Buresová I; Kyjovská D; Kovárová L; Moravcová J; Suská R; Perutka T; Cumová J; Hájek R
    Klin Onkol; 2011; 24(1):35-40. PubMed ID: 21542274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone marrow biopsy in multiple myeloma: a clinical pathological study.
    Aghai E; Avni G; Lurie M; Quitt M; Hornstein L; Froom P
    Isr J Med Sci; 1988 Jun; 24(6):298-301. PubMed ID: 3403226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Computed tomography in diagnosis and management of multiple myeloma and its variants.
    Kyle RA; Schreiman JS; McLeod RA; Beabout JW
    Arch Intern Med; 1985 Aug; 145(8):1451-2. PubMed ID: 4026477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.